Payments to Acquire Property, Plant, and Equipment of Krystal Biotech, Inc. from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Krystal Biotech, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • Krystal Biotech, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $6,204,000, a 392% increase year-over-year.
  • Krystal Biotech, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $11,951,000, a 182% increase from 2024.
  • Krystal Biotech, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $4,238,000, a 64% decline from 2023.
  • Krystal Biotech, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $11,799,000, a 78% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Krystal Biotech, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $11,951,000 +$7,713,000 +182% 01 Jan 2025 31 Dec 2025 10-K 17 Feb 2026 2025 FY
2024 $4,238,000 -$7,561,000 -64% 01 Jan 2024 31 Dec 2024 10-K 17 Feb 2026 2025 FY
2023 $11,799,000 -$41,180,000 -78% 01 Jan 2023 31 Dec 2023 10-K 17 Feb 2026 2025 FY
2022 $52,979,000 -$15,357,000 -22% 01 Jan 2022 31 Dec 2022 10-K 19 Feb 2025 2024 FY
2021 $68,336,000 +$53,493,000 +360% 01 Jan 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
2020 $14,843,000 +$8,444,000 +132% 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023 2021 FY
2019 $6,399,000 +$4,165,000 +186% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2021 2020 FY
2018 $2,234,000 +$2,024,000 +964% 01 Jan 2018 31 Dec 2018 10-K 10 Mar 2020 2019 FY
2017 $210,000 +$195,000 +1300% 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2018 2017 FY
2016 $15,000 01 Jan 2016 31 Dec 2016 10-K 12 Mar 2018 2017 FY

Krystal Biotech, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $6,204,000 +$4,944,000 +392% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $1,260,000 -$4,121,000 -77% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $5,381,000 -$11,810,000 -69% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024 2024 Q1
Q1 2022 $17,191,000 +$14,718,000 +595% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q1 2021 $2,473,000 +$965,000 +64% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q1 2020 $1,508,000 -$199,000 -12% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $1,707,000 01 Jan 2019 31 Mar 2019 10-Q 04 May 2020 2020 Q1
Q1 2017 $7,000* 01 Jan 2017 31 Mar 2017 10-Q 07 May 2018 2018 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.